GlaxoSmithKline


Recent News About GlaxoSmithKline View More

SCOTUS weighs competing briefs in widow's appeal in case vs GSK over suicide of lawyer taking generic Paxil

By Jonathan Bilyk | Apr 17, 2019

The U.S. Supreme Court is tackling the question of whether drug companies can be sued for not making their warning labels strong enough, even though the FDA controls the labels. But whether a forthcoming Supreme Court decision will affect a decision denying a $3 million judgment to the widow of a Chicago lawyer who committed suicide after taking the generic equivalent of Paxil remains unclear.

Massachusetts product liability ruling may have bearing on GSK appeal of $3M verdict over lawyer's suicide

By Karen Kidd | Apr 13, 2018

The thinking behind a Massachusetts ruling that brand-name manufacturers can he held liable for injuries suffered by patients who take generic versions of the drug those manufacturers innovate could have bearing in a case before a federal appeals court in Chicago.

GSK appeals $3M verdict over lawyer's suicide, Paxil labeling

By Jonathan Bilyk | Sep 29, 2017

About two weeks after a Chicago federal judge turned down its request for a new trial, pharmaceutical maker GlaxoSmithKline has formally appealed the judicial decisions the company has contended led to a jury improperly awarding $3 million to the widow of a Chicago lawyer who committed suicide by stepping in front of a train in Chicago’s Loop after taking a generic version of Paxil, an antidepressant developed by GSK.

The Record Network